messag turn solid headlin modest revenu upsid
compani four busi segment strong oper leverag
manag reiter cc revenu growth guidanc rais ep outlook
driven part lower interest expens tax rate
manag continu tri shift investor attent pipelin rather
current busi perform see reason optim front
regulatori timelin key program like robot still unclear other
still month away impact see share fairli valu
earn guidanc move higher manag continu see sale grow
constant currenc basi growth acceler cours year
meanwhil expect full year earn come cc
vs previous much improv come line howev
chang ebita guidanc interest expens tax expect
favor rel manag last updat
rais adjust ep estim cc
previous midpoint manag guidanc rang
model call total revenu cc prior estim
turn busi unit cvg forecast roughli flat growth cardiac
rhythm heart failur cc boost strength coronari
structur heart cc aortic peripher vascular
cc mitg expect surgic solut revenu come cc
respiratori gastrointestin renal ad sale cc meanwhil
expect rtg growth pace strength brain therapi cc
specialti therapi cc spine cc pain
therapi cc lag behind final expect diabet revenu come
cc full year overal like backend load year
model call growth rebound roughli first
half comp eas ep growth ramp sequenti well
somewhat underwhelm outlook tap expect
continu tri focu investor attent long-term pipelin process
kick anoth gear next month compani showcas much-anticip soft
tissu robot surgeri system intrigu find mani compani key program
howev continu see pipelin stori
meantim see stock fairli valu current level given present state
busi maintain neutral rate
sector medic suppli devic
page analyst certif import disclosur
wake covidien merger emerg largest med-tech
compani world boast lead franchis across wide varieti end market
sinc compani work translat unmatch scale competit
advantag includ lead way healthcar landscap shift fee-for-
valu model re-envis mean centuri
devic compani pursu goal deliv econom valu uniqu
combin technolog servic go far beyond tradit purview
med-tech effort mix success date think concept
valu healthcar stay expect fee-for-valu transit play
meantim see execut around compani core financi target
primari driver valu creation front think manag revis
lrp set much achiev bar one could even allow compani deliv
upsid street expect time pipelin matur near term howev
see stock fairli valu given growth trajectori
share current trade ntm ep estim
ntm ebitda repres discount large-cap med-tech group averag
respect view valuat appropri given medtron
project long-term growth profil top bottom line
respect lag behind broader sector averag approxim
respect better opportun elsewher group view assign
upsid risk rate includ revenu growth exce forecast better-
than-expect execut margin target faster expect shift fee-for-
valu healthcar paradigm benefit compani superior scale play
medtron strength prove disrupt competitor
downsid risk rate includ clinic setback weaker-than-expect adopt
new product caus revenu fall short street estim better-than-expect
share gain competitor failur execut margin expans goal
page analyst certif import disclosur
million usd except
good sold
compani report guggenheim secur llc estim
page analyst certif import disclosur
million usd
compani report guggenheim secur llc estim
page analyst certif import disclosur
